It is a light and breezy week here in California and at Your ERISA Watch. So, we have no case of the week and just a few covered decisions. Of note is an interesting attorneys’ fee decision from the Sixth Circuit, and two decision on petitions for interlocutory review under 28 U.S.C. § 1292(b)
After the flood of end-of-reporting-period decisions issued over the past several weeks, the tide has turned. This week we report on only eight cases. So relax and enjoy reading this week’s short but interesting selection of ERISA decisions, including one holding that 401(k) plan participants have adequately stated excessive fee claims, another reluctantly holding that
Navarro v. Wells Fargo & Co., No. 24-cv-3043 (LMP/DTS), 2025 WL 897717 (D. Minn. Mar. 24, 2025) (Judge Laura M. Provinzino)
We have been watching cases alleging that fiduciaries are mismanaging prescription drug benefit programs at Your ERISA Watch for several years now. These lawsuits contend that plan sponsors and fiduciaries of ERISA-governed healthcare